Cargando…
Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial Office of Gut and Liver
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444114/ https://www.ncbi.nlm.nih.gov/pubmed/34521776 http://dx.doi.org/10.5009/gnl210345 |
| _version_ | 1784568426410278912 |
|---|---|
| author | Park, Jihye Cheon, Jae Hee |
| author_facet | Park, Jihye Cheon, Jae Hee |
| author_sort | Park, Jihye |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8444114 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Editorial Office of Gut and Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84441142021-09-22 Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease? Park, Jihye Cheon, Jae Hee Gut Liver Editorial Editorial Office of Gut and Liver 2021-09-15 2021-09-15 /pmc/articles/PMC8444114/ /pubmed/34521776 http://dx.doi.org/10.5009/gnl210345 Text en Copyright © Gut and Liver. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Park, Jihye Cheon, Jae Hee Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease? |
| title | Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease? |
| title_full | Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease? |
| title_fullStr | Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease? |
| title_full_unstemmed | Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease? |
| title_short | Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease? |
| title_sort | can anti-tumor necrosis factor agents be discontinued in patients with inflammatory bowel disease? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444114/ https://www.ncbi.nlm.nih.gov/pubmed/34521776 http://dx.doi.org/10.5009/gnl210345 |
| work_keys_str_mv | AT parkjihye canantitumornecrosisfactoragentsbediscontinuedinpatientswithinflammatoryboweldisease AT cheonjaehee canantitumornecrosisfactoragentsbediscontinuedinpatientswithinflammatoryboweldisease |